Department of Cardiology, Yue Bei People's Hospital, Shantou University Medical College, Shaoguan, China.
Shaoguan College of Medicine, Shaoguan, China.
Ren Fail. 2023 Dec;45(1):2220420. doi: 10.1080/0886022X.2023.2220420.
High-sensitivity cardiac troponin T (hs-cTnT) and creatine kinase (CK)-MB are the most commonly used biomarkers for the diagnosis and prognosis of acute myocardial infarction (AMI). Chronic kidney disease (CKD) often leads to elevated hs-cTnT levels in non-AMI patients. However, studies comparing the prognostic value of both hs-cTnT and CK-MB in patients with AMI and CKD are lacking. We conducted a retrospective study on AMI patients diagnosed between January 2015 and October 2020. Patients were categorized based on renal function as normal or CKD. Peak hs-cTnT and CK-MB levels during hospitalization were collected, and their diagnostic value was evaluated using receiver operating characteristic (ROC) curves. The impact on in-hospital mortality was analyzed using multivariate logistic regression. The relationship between the hs-cTnT/CK-MB ratio and in-hospital death was examined using a restricted cubic spline (RCS) curve. The study included 5022 AMI patients, of whom 797 (15.9%) had CKD. The AUCs of Hs-cTnT and CK-MB were higher in the CKD group [0.842 (95% CI: 0.789-0.894) and 0.821 (95% CI: 0.760-0.882)] than in the normal renal function group [0.695 (95% CI: 0.604-0.790) and 0.708 (95% CI: 0.624-0.793)]. After full adjustment for all risk factors, hs-cTnT (OR, 2.82; 95% CI, 1.03-9.86; = 0.038) and CK-MB (OR, 4.91; 95% CI, 1.54-14.68; = 0.007) above the cutoff values were independent predictors of in-hospital mortality in patients with CKD. However, in patients with normal renal function, only CK-MB above the cutoff (OR, 2.45; 95% CI, 1.02-8.24; = 0.046) was a predictor of in-hospital mortality, whereas hs-cTnT was not. There was an inverted V-shaped relationship between the hs-cTnT/CK-MB ratio and in-hospital mortality, with an inflection point of 19.61. The ratio within the second quartile (9.63-19.6) was an independent predictor of in-hospital mortality in patients with CKD (OR 5.3, 95% CI 1.66-16.86, = 0.005). Hs-cTnT independently predicted in-hospital mortality in AMI patients with CKD, whereas its predictive value was not observed in patients with normal renal function. CK-MB was an independent predictor of in-hospital mortality regardless of renal function. Moreover, the hs-cTnT/CK-MB ratio may aid in risk stratification of AMI patients with CKD.
高敏肌钙蛋白 T(hs-cTnT)和肌酸激酶同工酶(CK-MB)是诊断和预测急性心肌梗死(AMI)的最常用生物标志物。慢性肾脏病(CKD)患者常伴有 hs-cTnT 水平升高,但目前缺乏比较 hs-cTnT 和 CK-MB 在 AMI 合并 CKD 患者中预后价值的研究。我们对 2015 年 1 月至 2020 年 10 月期间诊断为 AMI 的患者进行了回顾性研究。根据肾功能将患者分为正常或 CKD。收集住院期间 hs-cTnT 和 CK-MB 的峰值水平,并使用接收者操作特征(ROC)曲线评估其诊断价值。采用多变量 logistic 回归分析其对住院死亡率的影响。使用受限立方样条(RCS)曲线分析 hs-cTnT/CK-MB 比值与住院死亡的关系。该研究纳入了 5022 例 AMI 患者,其中 797 例(15.9%)患有 CKD。与肾功能正常组[0.695(95%CI:0.604-0.790)和 0.708(95%CI:0.624-0.793)]相比,CKD 组 hs-cTnT 和 CK-MB 的 AUC 更高[0.842(95%CI:0.789-0.894)和 0.821(95%CI:0.760-0.882)]。在对所有危险因素进行完全调整后,hs-cTnT(OR,2.82;95%CI,1.03-9.86; = 0.038)和 CK-MB(OR,4.91;95%CI,1.54-14.68; = 0.007)超过截断值是 CKD 患者住院死亡率的独立预测因素。然而,在肾功能正常的患者中,只有 CK-MB 超过截断值(OR,2.45;95%CI,1.02-8.24; = 0.046)与住院死亡率相关,而 hs-cTnT 则无。hs-cTnT/CK-MB 比值与住院死亡率呈倒 V 形关系,拐点为 19.61。第二四分位数(9.63-19.6)内的比值是 CKD 患者住院死亡率的独立预测因素(OR 5.3,95%CI 1.66-16.86, = 0.005)。hs-cTnT 可独立预测 CKD 合并 AMI 患者的住院死亡率,而在肾功能正常的患者中未观察到其预测价值。CK-MB 是住院死亡率的独立预测因素,而与肾功能无关。此外,hs-cTnT/CK-MB 比值可能有助于 CKD 合并 AMI 患者的风险分层。